Srikanth Radhakrishnan insider trades: Pulmonx (LUNG) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Srikanth reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | LUNG | ↓ Sell | 14,245 | $2.26 | $32K | Direct | Sep 3, 2026 (2d) |
| Jun 1, 2026 | LUNG | ↓ Sell | 14,497 | $1.54 | $22K | Direct | Jun 3, 2026 (2d) |
| Mar 2, 2026 | LUNG | ↓ Sell | 10,483 | $1.43 | $15K | Direct | Mar 4, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LUNG insiders
Open-market trades in the last 12 months
About Srikanth Radhakrishnan's insider trades
Srikanth Radhakrishnan is Chief Science & Techn. Officer at Pulmonx (LUNG). Since Mar 2, 2026, Srikanth has reported no open-market purchases and 3 sales worth $70K on SEC Form 4. In the last 12 months: 3 sales ($70K).
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LUNG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.